DSIJ Mindshare

After two straight days of gains, will it stop raining gains for Indian markets? Well, the subdued cues from the Asian peers and the disappointing data from the US overnight are certainly pointing at a shaky start. The SGX Nifty at the time of writing is seen trading down by 20 points at 10,793. 

Zydus Cadila has received the final approval from the USFDA to market Phytonadione Tablets. The group also received the final approval for Colchicine Tablets USP (US RLD - Colcrys), 0.6 mg.

The stock of Ashoka Buildcon was up more than 9 per cent on Thursday as the company was declared as the Lowest Bidder by the NHAI for the Tumkur – Shivamogga section, near Bengaluru, Karnataka.

The company plans to buyback around 2.10 per cent of it paid-up equity capital for not more than Rs. 1,956 crore. Following the announcement, the stock hit 52-week high on Thursday.

The Supreme Court of India has given a decision in favour of popular painkiller Saridon by exempting its formulation from the list of banned FDCs (Fixed Dose Combinations).